Related Experiment Video
Updated: Aug 19, 2026
LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
Published on: May 3, 2024
Gaudichaudione H induces GSDME-mediated pyroptosis and apoptosis in esophageal squamous cell carcinoma via
Ziyi Bao1, Guangtao Zhang2, Mijia Shao3
1The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Background:
Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with limited therapeutic options. Therefore, novel treatment strategies are urgently needed.
Purpose:
This study aimed to evaluate the antitumor effects of Gaudichaudione H (GH), a natural caged xanthone isolated from Garcinia oligantha Merr., and to elucidate its underlying mechanisms with a focus on cell death regulation in ESCC.
Methods:
The antitumor activity of GH was evaluated in ESCC cell lines (KYSE150, KYSE450, Eca-109) and a xenograft mouse model. Cell viability, LDH release, morphological changes, and protein expression were assessed. RNA sequencing, pharmacological inhibitors, and genetic manipulation of YAP (knockdown and overexpression) were used to investigate the underlying mechanism.
Results:
GH exhibited dose-dependent cytotoxicity against ESCC cell lines, with IC₅₀ values ranging from 5.7 to 7.9 μM in KYSE150, KYSE450, and Eca-109 cells. GH induced apoptotic and pyroptotic morphological features accompanied by increased LDH release in a caspase-3-dependent manner. Transcriptomic analysis revealed enrichment of the MAPK/JNK signaling pathway. Mechanistically, GH elevated intracellular ROS levels, leading to ubiquitin-proteasome-dependent degradation of YAP. Loss of YAP activated JNK signaling, resulting in caspase-3 activation and GSDME cleavage. ROS scavenging or JNK inhibition significantly attenuated GH-induced cell death. In vivo, GH inhibited tumor growth by approximately 75% compared with the vehicle-treated group in a xenograft model without observable systemic toxicity.
Conclusion:
GH induces ESCC cell death through a ROS-dependent YAP ubiquitination axis involving JNK signaling activation, which regulates the crosstalk between apoptosis and pyroptosis in ESCC. These findings highlight GH as a promising natural lead compound for ESCC therapy.
Abbreviations:
CHX, Cycloheximide; DMSO, Dimethyl sulfoxide; ECL, Enhanced chemiluminescence; ESCC, Esophageal squamous cell carcinoma; GSDME, Gasdermin E; GH, Gaudichaudione H; JNK, c-Jun N-terminal kinase; KEGG, Kyoto Encyclopedia of Genes and Genomes; LDH, Lactate dehydrogenase; MAPK, Mitogen-activated protein kinase; NAC, N-acetylcysteine; PARP, Poly(ADP-ribose) polymerase; PBS, Phosphate-buffered saline; PCD, Programmed cell death; PPI, Protein-protein interaction; RNA-seq, RNA sequencing; ROS, Reactive oxygen species; siRNA, Small interfering RNA; YAP, Yes-associated protein.
Insights
Gaudichaudione H (GH) effectively kills esophageal squamous cell carcinoma (ESCC) cells by triggering programmed cell death pathways. This natural compound shows promise as a novel therapeutic for ESCC, inhibiting tumor growth in mice.
Area of Science:
- Molecular Oncology
- Natural Product Chemistry
- Cancer Therapeutics
Background:
- Esophageal squamous cell carcinoma (ESCC) is an aggressive cancer with limited treatment options.
- Novel therapeutic strategies are crucial for improving patient outcomes in ESCC.
- Natural compounds offer potential avenues for developing new cancer treatments.
Purpose of the Study:
- To investigate the antitumor effects of Gaudichaudione H (GH), a xanthone from Garcinia oligantha Merr., against ESCC.
- To elucidate the mechanisms underlying GH's action, focusing on cell death regulation in ESCC.
- To evaluate GH's efficacy and safety in preclinical models of ESCC.
Main Methods:
- Antitumor activity of GH assessed in ESCC cell lines (KYSE150, KYSE450, Eca-109) and a xenograft mouse model.
- Cell viability, lactate dehydrogenase (LDH) release, and morphological changes were measured.
- Mechanisms investigated using RNA sequencing, pharmacological inhibitors, and YAP (Yes-associated protein) manipulation.
Main Results:
- GH demonstrated dose-dependent cytotoxicity against ESCC cells (IC₅₀: 5.7–7.9 μM).
- GH induced apoptosis and pyroptosis via a caspase-3-dependent pathway, involving ROS generation and YAP degradation.
- GH significantly inhibited tumor growth (~75%) in vivo without systemic toxicity, linked to JNK pathway activation.
Conclusions:
- GH triggers ESCC cell death through a reactive oxygen species (ROS)-dependent mechanism involving YAP ubiquitination and JNK signaling.
- This pathway regulates the interplay between apoptosis and pyroptosis, offering a novel therapeutic strategy for ESCC.
- Gaudichaudione H represents a promising natural lead compound for the development of new ESCC therapies.
Related Concept Videos
01:30Apoptosis
01:17The Extrinsic Apoptotic Pathway
01:31The Intrinsic Apoptotic Pathway
01:22Cellular Injury V: Apoptosis and Autophagy
01:27Esophageal Achalasia